Next |
home / stock / hils / hils message board
Subject | By | Source | When |
---|---|---|---|
$HILS .4702 Randy Milby - CEO & Chairman | BooDog | investorshub | 04/28/2023 2:01:37 PM |
lol, yup. it's a wierd relationship when you | BooDog | investorshub | 04/28/2023 12:52:35 PM |
Yuck | Awl416 | investorshub | 04/28/2023 12:09:56 PM |
... today announced the pricing of an underwritten | BooDog | investorshub | 04/28/2023 10:20:25 AM |
$HILS MomentumIts now last up | harry crumb | investorshub | 04/27/2023 10:10:46 PM |
znewcar1: $HILS 53% v14,7M c1.09 f11,5M H1.26 ML.67 | znewcar1 | investorshangout | 04/27/2023 8:35:01 PM |
here we go bulls news is here | harry crumb | investorshub | 04/27/2023 4:31:46 PM |
News? | Awl416 | investorshub | 04/27/2023 1:28:09 PM |
what does this mean? | subslover | investorshub | 04/27/2023 4:29:21 AM |
$HILS MomentumIts trading up | gail | investorshub | 04/27/2023 12:30:29 AM |
$HILS MomentumIts now up | PennyPusher786 | investorshub | 04/26/2023 11:24:49 PM |
Good news recently, we should start to see this one move | gail | investorshub | 04/26/2023 6:56:30 PM |
Price now | Triple nickle | investorshub | 04/26/2023 2:06:36 PM |
$HILS just the news we needed | harry crumb | investorshub | 04/26/2023 1:24:28 PM |
$HILS MomentumIts now last up | Runners123 | investorshub | 04/26/2023 6:46:55 AM |
The trading | harry crumb | investorshub | 04/26/2023 2:49:09 AM |
$HILS Found an interesting article | harry crumb | investorshub | 04/26/2023 2:28:36 AM |
$HILS Do we have a winner?Turn around time? | Runners123 | investorshub | 04/25/2023 7:25:09 PM |
$HILS short data if anyone is interested | subslover | investorshub | 04/25/2023 1:10:56 PM |
$HILS MomentumIts gaining last up | harry crumb | investorshub | 04/25/2023 9:00:10 AM |
News, Short Squeeze, Breakout and More Instantly...
Hillstream BioPharma Inc. Company Name:
HILS Stock Symbol:
NASDAQ Market:
Expects to launch and complete a Phase 1 trial in Q4 2023 Tharimmune to begin trading under new ticker, THAR, on Monday September 25, 2023 BRIDGEWATER, NJ / ACCESSWIRE / September 22, 2023 / Hillstream BioPharma Inc., (NASDAQ:HILS), a biotechnology company developing innovative therapeu...
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...
Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the next approximately 12 months Seeking first approval in an orphan disease, PBC, for the treatment of moderate to severe chronic pruritis in which more than 70% of patients suffer from chronic prur...